Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Plaza equity offering
We advised Plaza on its equity offering
NTT Finance $2.35 billion senior notes offering
The investment-grade notes were issued in three tranches
China Great Wall $200 million bonds and $300 million perpetual securities
The bonds and perpetual securities were offered under Regulation S
Essent Group $500 million senior notes offering
The 6.25% investment-grade senior notes are due 2029
Recursion Pharmaceuticals $230 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
InflaRx $75 million at-the-market offering
The shares are listed on the Nasdaq Global Market
XP $500 million senior notes offering and concurrent tender offer
We advised XP on its Rule 144A / Regulation S unsecured notes offering and concurrent tender offer
Peru $4.07 billion sovereign bond issuance and offers to tender and exchange
We advised Peru on the transactions
CCC Intelligent Solutions Holdings $339 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Millicom tender offer by Atlas Luxco
We are advising Millicom’s independent committee on the tender offer